Y-Intercept (HK)’s Definium Therapeutics DFTX Stock Holding History

Y-Intercept (HK)’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.56M	Buy	+54,466	New	+$1.35M	0.05%	565
2024 Q2	–	Sell	-23,316	Closed	-$219K	–	1716
2024 Q1	$219K	Buy	23,316 +6,463	+38%	+$36.9K	0.02%	1104
2023 Q4	$61.7K	Buy	+16,853	New	+$50.7K	0.01%	1143
2022 Q3	–	Sell	-9,806	Closed	-$94K	–	1158
2022 Q2	$94K	Buy	+9,806	New	+$124K	0.01%	723

Other funds holding DFTX

Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return

Bay Rivers Group Williamsburg, Virginia $293M AUM 48.17% 1-Year Est. Return

Stableford Capital II Scottsdale, Arizona $289M AUM 20.84% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.6B AUM 29.42% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

Ares Financial Consulting Calabasas, California $139M AUM